These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16192820)

  • 1. Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.
    Posther KE; McCall LM; Blumencranz PW; Burak WE; Beitsch PD; Hansen NM; Morrow M; Wilke LG; Herndon JE; Hunt KK; Giuliano AE
    Ann Surg; 2005 Oct; 242(4):593-9; discussion 599-602. PubMed ID: 16192820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
    Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
    JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National practice patterns of sentinel lymph node dissection for breast carcinoma.
    Lucci A; Kelemen PR; Miller C; Chardkoff L; Wilson L
    J Am Coll Surg; 2001 Apr; 192(4):453-8. PubMed ID: 11294401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
    Giuliano AE; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Hunt KK; Morrow M; Ballman K
    Ann Surg; 2010 Sep; 252(3):426-32; discussion 432-3. PubMed ID: 20739842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.
    Weiss A; Mittendorf EA; DeSnyder SM; Hwang RF; Bea V; Bedrosian I; Hoffman K; Adrade B; Sahin AA; Kuerer HM; Hunt KK; Caudle AS
    Clin Breast Cancer; 2018 Aug; 18(4):276-281. PubMed ID: 29100726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.
    Yi M; Kuerer HM; Mittendorf EA; Hwang RF; Caudle AS; Bedrosian I; Meric-Bernstam F; Wagner JL; Hunt KK
    J Am Coll Surg; 2013 Jan; 216(1):105-13. PubMed ID: 23122536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection.
    Nayyar A; Strassle PD; Shen MR; Black JA; Gallagher KK; McGuire KP
    Am J Surg; 2018 Oct; 216(4):706-712. PubMed ID: 30060915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.
    Nason KS; Anderson BO; Byrd DR; Dunnwald LK; Eary JF; Mankoff DA; Livingston R; Schmidt RA; Jewell KD; Yeung RS; Moe RE
    Cancer; 2000 Dec; 89(11):2187-94. PubMed ID: 11147588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
    Chung MH; Ye W; Giuliano AE
    Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
    Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
    Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC; Suman VJ; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Leitch AM; Kuerer HM; Bowling M; Flippo-Morton TS; Byrd DR; Ollila DW; Julian TB; McLaughlin SA; McCall L; Symmans WF; Le-Petross HT; Haffty BG; Buchholz TA; Nelson H; Hunt KK;
    JAMA; 2013 Oct; 310(14):1455-61. PubMed ID: 24101169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
    Giuliano AE; Haigh PI; Brennan MB; Hansen NM; Kelley MC; Ye W; Glass EC; Turner RR
    J Clin Oncol; 2000 Jul; 18(13):2553-9. PubMed ID: 10893286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
    Haigh PI; Hansen NM; Qi K; Giuliano AE
    Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.